Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Pilocarpine on Salivary Gland Absorbed Dose in Radioiodine Therapy
IRCT2014060917684N3Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pilocarpine in well-differentiated thyroid cancer (WDTC), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Absorbed salivary gland radiation dose. Started Nov 2014; status: completed.
02
Drugs
pilocarpine
03
Conditions
well-differentiated thyroid cancer (WDTC)
Beyond the preview
Go deeper on IRCT2014060917684N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014060917684N3.